Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. British Journal of Cancer. 2003;89(6):1028-1030. doi:10.1038/sj.bjc.6601242.

Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. British Journal of Cancer. 2004;90(9):1704-1706. doi:10.1038/sj.bjc.6601789.

McMillan DC et. al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis. 2007 Aug;22(8):881-6. Epub 2007 Jan 24.

Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010 Jan;6(1):149-63. doi: 10.2217/fon.09.136.

Proctor MJ, Talwar D, Balmar SM, et al. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. British Journal of Cancer. 2010;103(6):870-876. doi:10.1038/sj.bjc.6605855.

Dr. Donald McMillan

Glasgow Prognostic Score (GPS) for Cancer Outcomes

<p>Provides cancer prognosis based on serum biomarkers.</p>

GPS for Cancer Outcomes

The Glasgow Prognostic Score provides prognoses for cancer patients based on serum biomarkers.

mGPS for Cancer Outcomes

Fong Score

Prognostic Index for Cancer

EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.

Listen to the VACO co-creators break down how to use VACO\, what it does\, and what it doesn’t.

Calc Function